Damian Green

Damian Green

Company: Fred Hutchinson Cancer Research Center (FHCRC)

Job title: Associate Professor - Clinical Research Division

Seminars:

Closing Panel Discussion: Future Directions for BCMA-Directed Therapies 4:00 pm

Pricing/Cost Accessibility changes Is improved trial design needed? How will they be commercialized? What is the ultimate limit of BCMA as a target for myeloma? How will cell therapy infrastructure evolve & how will this effect current situation? Potential limitations to BCMA and how other targets (FcRb5/FcR115, NC28, CS1, SIRH5) could fit in the future…Read more

day: Day Two

Chair’s Opening Remarks 8:50 am

Read more

day: Day Two

Leveraging the Findings From First in-Human GSI-plus-BCMA Clinical Trial to Understand Mechanisms of Resistance & Optimize Efficacy 11:30 am

Exploring why mechanisms of resistance to BCMA targeted therapies require further elucidation Understanding the impact of BCMA antigen density on response, needing to be further characterized Discussing why the approach to sequencing BCMA targeting agents may require careful considerationRead more

day: Day One

Chair’s Opening Remarks 9:20 am

Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.